Tear Lipidome Analysis for Ophthalmic Diseases, establishment of new biomarkers

Tear Lipidome Analysis for Ophthalmic Diseases, establishment of new biomarkers - Tear Lipidome Analysis for Ophthalmic Diseases, establishment of new biomarkers

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036248

Enrollment

Registered

2019-03-18

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ocular disease

Interventions

At the time of outpatient visit, tears are collected for 5 minutes in Schirmer test.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: anterior segment disease

Exclusion criteria

Exclusion criteria: History of eyedrops treatment History of eyesurgery

Design outcomes

Primary

Measure	Time frame
The tears are collected with Schirmer's test paper for 5 minutes from patients who obtained informed consent at the visit to the outpatient clinic, and then comprehensive concentration measurement of extracted lipids is performed using a mass spectrometer	—

Countries

Japan

Contacts

Public ContactYUKINOBU OKAJIMA

Toho University omori medical center Opthalmology

yukinobu.okajima@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026